(Q38150638)

29 August 2017

title

Role of type 1 natural killer T cells in pulmonary immunity (English)

1 reference

29 August 2017

C Paget

1

0 references

author name string

F Trottein

series ordinal

2

1 reference

29 August 2017

publication date

9 October 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

6

1 reference

29 August 2017

issue

6

1 reference

29 August 2017

page(s)

1054-1067

1 reference

https://scigraph.springernature.com/pub.10.1038/mi.2013.59

29 August 2017

exact match

0 references

cites work

The biology of NKT cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Going both ways: immune regulation via CD1d-dependent NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Immunomodulatory type II natural killer T lymphocytes in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Recognition of CD1d-restricted antigens by natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

The contrasting roles of NKT cells in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

A semi-invariant Vα10+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Raising the NKT cell family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Microbial exposure during early life has persistent effects on natural killer T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Airborne lipid antigens mobilize resident intravascular NKT cells to induce allergic airway inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Bronchoalveolar lavage invariant natural killer T cells are not increased in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Invariant NKT cells sustain specific B cell responses and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Antigen-specific cytotoxicity by invariant NKT cells in vivo is CD95/CD178-dependent and is correlated with antigenic potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Interactions between NKT cells and Tregs are required for tolerance to combined bone marrow and organ transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Ly49 C/I-dependent NKT cell-derived IL-10 is required for corneal graft survival and peripheral tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

The unique role of natural killer T cells in the response to microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Differential antitumor immunity mediated by NKT cell subsets in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Induction of airway hyperreactivity by IL-25 is dependent on a subset of invariant NKT cells expressing IL-17RB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Skin and peripheral lymph node invariant NKT cells are mainly retinoic acid receptor-related orphan receptor (gamma)t+ and respond preferentially under inflammatory conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Cutting edge: crucial role of IL-1 and IL-23 in the innate IL-17 response of peripheral lymph node NK1.1- invariant NKT cells to bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Th17 cytokines and mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Presumed guilty: natural killer T cell defects and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

The role of invariant NKT cells in allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Natural killer T cells and X-linked lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Anti-tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

NKT-cell-based immunotherapies in clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Harnessing invariant NKT cells in vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Role of natural killer T lymphocytes during helminthic infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Germline-encoded recognition of diverse glycolipids by natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Recognition of bacterial glycosphingolipids by natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

How invariant natural killer T cells respond to infection by recognizing microbial or endogenous lipid antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Mechanism of CD1d-restricted natural killer T cell activation during microbial infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Lysosomal alpha-galactosidase controls the generation of self lipid antigens for natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Role of invariant NK T lymphocytes in immune responses to CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Cross-presentation of disialoganglioside GD3 to natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Recognition of lyso-phospholipids by human natural killer T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Lipid and glycolipid antigens of CD1d-restricted natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

NKT cells are critical for the initiation of an inflammatory bowel response against Toxoplasma gondii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Abundance of unconventional CD8(+) natural killer T cells in the large intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

CD161+ T (NT) cells exist predominantly in human intestinal epithelium as well as in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Significance of para-esophageal lymph nodes in food or aeroallergen-induced iNKT cell-mediated experimental eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Invariant natural killer T cells from children with versus without food allergy exhibit differential responsiveness to milk-derived sphingomyelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Role of NKT cells in the digestive system. IV. The role of canonical natural killer T cells in mucosal immunity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Role of NKT cells in the digestive system. III. Role of NKT cells in intestinal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

The role of CD1d in the immune response against Listeria infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Rapid development of a gamma interferon-secreting glycolipid/CD1d-specific Valpha14+ NK1.1- T-cell subset after bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Invariant V alpha 14+ NKT cells participate in the early response to enteric Listeria monocytogenes infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Exacerbated susceptibility to infection-stimulated immunopathology in CD1d-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Interruption of CXCL13-CXCR5 axis increases upper genital tract pathology and activation of NKT cells following chlamydial genital infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Protective role of α-galactosylceramide-stimulated natural killer T cells in genital tract infection with Chlamydia muridarum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Innate and adaptive immune responses in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Natural killer T cells in the lungs of patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Functional invariant NKT cells in pig lungs regulate the airway hyperreactivity: a potential animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

A CD1d-dependent antagonist inhibits the activation of invariant NKT cells and prevents development of allergen-induced airway hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

The role of endotoxin and its receptors in allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Invariant NKT cells are required for airway inflammation induced by environmental antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Human CD1-restricted T cell recognition of lipids from pollens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Suppression of eosinophilic airway inflammation by treatment with alpha-galactosylceramide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Role of NKT cells in allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Natural killer T cells are not the predominant T cell in asthma and likely modulate, not cause, asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Natural killer T cells are important in the pathogenesis of asthma: the many pathways to asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Invariant natural killer T cells and asthma: Immunologic reality or methodologic artifact?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

NKT cells in the induced sputum of severe asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Direct activation of natural killer T cells induces airway hyperreactivity in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Chronic obstructive pulmonary disease: current burden and future projections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Global burden of COPD: risk factors, prevalence, and future trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Activation of pulmonary invariant NKT cells leads to exacerbation of acute lung injury caused by LPS through local production of IFN-γ and TNF-α by Gr-1+ monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Treatment with alpha-galactosylceramide attenuates the development of bleomycin-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

E- and P-selectins synergistically inhibit bleomycin-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

IL-4-secreting NKT cells prevent hypersensitivity pneumonitis by suppressing IFN-gamma-producing neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Influenza: old and new threats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

New look at an old problem: bacterial superinfection after influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Activation of invariant NKT cells enhances the innate immune response and improves the disease course in influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Pivotal Advance: Invariant NKT cells reduce accumulation of inflammatory monocytes in the lungs and decrease immune-pathology during severe influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Mechanism of NKT cell activation by intranasal coadministration of alpha-galactosylceramide, which can induce cross-protection against influenza viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

α-Galactosylceramide potently augments M2e-induced protective immunity against highly pathogenic H5N1 avian influenza virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

A single intranasal immunization with inactivated influenza virus and alpha-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Lack of PD-L1 expression by iNKT cells improves the course of influenza A infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Critical role of natural killer cells in lung immunopathology during influenza infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

NK cells exacerbate the pathology of influenza virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

IL-22 is essential for lung epithelial repair following influenza infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Pathogenesis, treatment, and prevention of pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Critical role of Valpha14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Key role for respiratory CD103(+) dendritic cells, IFN-γ, and IL-17 in protection against Streptococcus pneumoniae infection in response to α-galactosylceramide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

CD1d-independent activation of invariant natural killer T cells by staphylococcal enterotoxin B through major histocompatibility complex class II/T cell receptor interaction results in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Differential regulation of cytokine production by CD1d-restricted NKT cells in response to superantigen staphylococcal enterotoxin B exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

NK T cell activation promotes Chlamydia trachomatis infection in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Distinct NKT cell subsets are induced by different Chlamydia species leading to differential adaptive immunity and host resistance to the infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Paradoxically high resistance of natural killer T (NKT) cell-deficient mice to Legionella pneumophila: another aspect of NKT cells for modulation of host responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Role of CD1d-restricted NKT cells in microbial immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Activation of NKT cells protects mice from tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Rapid NKT cell responses are self-terminating during the course of microbial infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Alteration of the relative levels of iNKT cell subsets is associated with chronic mycobacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

High granulocyte/lymphocyte ratio and paucity of NKT cells defines TB disease in a TB-endemic setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer T cells in fast treatment responders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Monocyte chemoattractant protein-1-dependent increase of V alpha 14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Innate recognition of cell wall β-glucans drives invariant natural killer T cell responses against fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Fine specificity of natural killer T cells against GD3 ganglioside and identification of GM3 as an inhibitory natural killer T-cell ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Diverse populations of T cells with NK cell receptors accumulate in the human intestine in health and in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Natural killer T cells in bronchial biopsies from human allergen challenge model of allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Participation of group 2 CD1 molecules in the control of murine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Role of T Cells in -Galactosylceramide-Mediated Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

NKT cell immune responses to viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

Activation of Invariant NKT Cells by Toll-like Receptor 9-Stimulated Dendritic Cells Requires Type I Interferon and Charged Glycosphingolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

7 January 2021

Regulatory roles of NKT cells in the induction and maintenance of cyclophosphamide-induced tolerance

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

7 January 2021

Oral tolerance to nickel requires CD4+ invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

7 January 2021

Role of NKT Cells in the Digestive System. II. NKT cells and diabetes

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

7 January 2021

NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL-10 and transforming growth factor beta, and by clonally deleting antigen-specific T cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

7 January 2021

Expression of CD1d in the duodenum of patients with cow's milk hypersensitivity

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

7 January 2021

-Galactosylceramide-Induced Airway Eosinophilia Is Mediated through the Activation of NKT Cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

7 January 2021

Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

7 January 2021

Natural killer T cells and CD8+ T cells are dispensable for T cell–dependent allergic airway inflammation

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

7 January 2021

Differential role of thymic stromal lymphopoietin in the induction of airway hyperreactivity and Th2 immune response in antigen-induced asthma with respect to natural killer T cell function

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

7 January 2021

Alpha-galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice: role of IFN-gamma

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

7 January 2021

Immune modulation of ovalbumin-induced lung injury in mice using β-glucosylceramide and a potential role of the liver

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

7 January 2021

The TLR7 agonist R848 alleviates allergic inflammation by targeting invariant NKT cells to produce IFN-gamma

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

7 January 2021

Enhanced frequency of immunoregulatory invariant natural killer T cells in the airways of children with asthma

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

7 January 2021

Case records of the Massachusetts General Hospital. Case 16-2006. A 72-year-old woman admitted to the emergency department because of a sudden change in mental status.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

7 January 2021

Chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

7 January 2021

CD1d-restricted IFN-γ-secreting NKT cells promote immune complex-induced acute lung injury by regulating macrophage-inflammatory protein-1α production and activation of macrophages and dendritic cells.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

7 January 2021

Epidemiology of influenza

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

7 January 2021

Role of interferon-γ in Vα14+ natural killer T cell-mediated host defense against Streptococcus pneumoniae infection in murine lungs

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

7 January 2021

NKT cells play a limited role in the neutrophilic inflammatory responses and host defense to pulmonary infection with Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

7 January 2021

Natural killer T (NKT) cell subsets in chlamydial infections

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

7 January 2021

An anti-inflammatory role for V alpha 14 NK T cells in Mycobacterium bovis bacillus Calmette-Guérin-infected mice

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

7 January 2021

Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.59

7 January 2021

Identifiers

DOI

10.1038/MI.2013.59

1 reference

Dimensions Publication ID

29 August 2017

1030846926

0 references

1 reference